🔴 Achieve Life Sciences is trading 6.77% down in pre-market with no clear company-specific catalyst identified

Achieve Life Sciences is trading 6.77% lower at $7.30, with no clear company-specific announcement identified for September 25, 2026.

• The decline contrasts with firmer broader markets: the Nasdaq Composite was up 0.71%, so macro sentiment does not clearly explain the move.
• Recent coverage discusses the FDA manufacturing-related setback and potential NDA resubmission, but predates the session and does not establish a new catalyst.